Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Postoperative Pain in Oral and Maxillofacial Surgery
NCT02957097Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin in postoperative pain, sponsored by Massachusetts General Hospital. Planned start Sep 2019; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02957097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957097.